Anne Libby
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mental Health Services | 11 | 2016 | 331 | 1.660 |
Why?
| Medicaid | 11 | 2024 | 411 | 1.650 |
Why?
| Financing, Organized | 4 | 2020 | 34 | 1.440 |
Why?
| Research Personnel | 5 | 2020 | 158 | 1.270 |
Why?
| Comparative Effectiveness Research | 4 | 2013 | 132 | 1.170 |
Why?
| Depressive Disorder, Major | 5 | 2009 | 303 | 1.050 |
Why?
| Indians, North American | 6 | 2008 | 598 | 0.990 |
Why?
| Substance-Related Disorders | 8 | 2008 | 971 | 0.960 |
Why?
| Nonprescription Drugs | 3 | 2016 | 67 | 0.960 |
Why?
| Biomedical Research | 5 | 2020 | 612 | 0.930 |
Why?
| Antidepressive Agents | 6 | 2015 | 189 | 0.910 |
Why?
| Managed Care Programs | 10 | 2011 | 135 | 0.870 |
Why?
| Mentoring | 3 | 2022 | 101 | 0.840 |
Why?
| Faculty, Medical | 4 | 2022 | 252 | 0.820 |
Why?
| Sex Factors | 7 | 2022 | 1781 | 0.820 |
Why?
| Depressive Disorder | 6 | 2015 | 333 | 0.810 |
Why?
| Mental Disorders | 5 | 2017 | 939 | 0.740 |
Why?
| Interdisciplinary Research | 1 | 2020 | 27 | 0.730 |
Why?
| Sex Characteristics | 3 | 2022 | 671 | 0.690 |
Why?
| United States Food and Drug Administration | 4 | 2009 | 175 | 0.650 |
Why?
| Emergency Services, Psychiatric | 1 | 2017 | 36 | 0.610 |
Why?
| Child Welfare | 4 | 2007 | 199 | 0.600 |
Why?
| Academic Medical Centers | 3 | 2020 | 422 | 0.600 |
Why?
| Writing | 1 | 2018 | 88 | 0.580 |
Why?
| Interdisciplinary Studies | 1 | 2016 | 26 | 0.580 |
Why?
| Mentors | 5 | 2022 | 166 | 0.570 |
Why?
| Child Abuse | 6 | 2008 | 466 | 0.570 |
Why?
| Academies and Institutes | 1 | 2016 | 44 | 0.560 |
Why?
| Prescription Drugs | 2 | 2016 | 113 | 0.560 |
Why?
| United States | 30 | 2024 | 12555 | 0.550 |
Why?
| Science | 1 | 2016 | 49 | 0.540 |
Why?
| Contract Services | 3 | 2002 | 10 | 0.530 |
Why?
| Capitation Fee | 4 | 2002 | 13 | 0.520 |
Why?
| Health Policy | 5 | 2016 | 333 | 0.520 |
Why?
| Quality-Adjusted Life Years | 3 | 2014 | 103 | 0.500 |
Why?
| Child Abuse, Sexual | 3 | 2007 | 82 | 0.500 |
Why?
| Colorado | 16 | 2020 | 4196 | 0.490 |
Why?
| Length of Stay | 2 | 2017 | 1032 | 0.480 |
Why?
| Health Care Costs | 2 | 2010 | 394 | 0.480 |
Why?
| Dibenzothiazepines | 1 | 2013 | 20 | 0.480 |
Why?
| Cooperative Behavior | 1 | 2016 | 408 | 0.470 |
Why?
| Humans | 74 | 2024 | 118974 | 0.470 |
Why?
| Fee-for-Service Plans | 4 | 2002 | 79 | 0.460 |
Why?
| Medication Therapy Management | 1 | 2014 | 72 | 0.460 |
Why?
| Data Collection | 5 | 2012 | 658 | 0.460 |
Why?
| Antihypertensive Agents | 3 | 2024 | 437 | 0.460 |
Why?
| Adolescent | 32 | 2017 | 18480 | 0.460 |
Why?
| Videoconferencing | 2 | 2017 | 59 | 0.440 |
Why?
| Cohort Studies | 13 | 2016 | 5116 | 0.440 |
Why?
| Suicide, Attempted | 3 | 2015 | 316 | 0.440 |
Why?
| Physicians | 4 | 2022 | 794 | 0.430 |
Why?
| Female | 47 | 2022 | 61565 | 0.430 |
Why?
| Cities | 1 | 2012 | 96 | 0.410 |
Why?
| Pharmacists | 1 | 2014 | 238 | 0.410 |
Why?
| Male | 44 | 2022 | 57801 | 0.410 |
Why?
| Income | 1 | 2012 | 173 | 0.410 |
Why?
| Antipsychotic Agents | 1 | 2013 | 193 | 0.400 |
Why?
| Unemployment | 1 | 2010 | 42 | 0.390 |
Why?
| Depression | 3 | 2014 | 1132 | 0.380 |
Why?
| Cost of Illness | 1 | 2012 | 258 | 0.380 |
Why?
| Plant Preparations | 1 | 2010 | 23 | 0.370 |
Why?
| Research Support as Topic | 3 | 2020 | 114 | 0.350 |
Why?
| Child, Preschool | 14 | 2017 | 9491 | 0.350 |
Why?
| Cost-Benefit Analysis | 6 | 2017 | 554 | 0.350 |
Why?
| Middle Aged | 28 | 2022 | 27617 | 0.350 |
Why?
| Telemedicine | 1 | 2017 | 664 | 0.340 |
Why?
| Prescriptions | 1 | 2009 | 63 | 0.340 |
Why?
| Tobacco Smoke Pollution | 1 | 2012 | 233 | 0.340 |
Why?
| Epilepsy | 1 | 2012 | 290 | 0.330 |
Why?
| Point-of-Care Systems | 1 | 2010 | 151 | 0.330 |
Why?
| Premature Birth | 1 | 2012 | 284 | 0.320 |
Why?
| Child | 23 | 2017 | 19129 | 0.320 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2007 | 765 | 0.320 |
Why?
| Health Maintenance Organizations | 2 | 2005 | 96 | 0.320 |
Why?
| Chronic Disease | 2 | 2013 | 1636 | 0.310 |
Why?
| Drug and Narcotic Control | 1 | 2007 | 28 | 0.300 |
Why?
| Combat Disorders | 1 | 2007 | 34 | 0.300 |
Why?
| Parents | 3 | 2017 | 1212 | 0.300 |
Why?
| Interview, Psychological | 1 | 2007 | 93 | 0.300 |
Why?
| Cross-Sectional Studies | 7 | 2017 | 4552 | 0.300 |
Why?
| Substance Withdrawal Syndrome | 1 | 2009 | 157 | 0.300 |
Why?
| Research Design | 3 | 2019 | 969 | 0.290 |
Why?
| Adult | 25 | 2019 | 31512 | 0.290 |
Why?
| Education, Medical | 2 | 2020 | 239 | 0.290 |
Why?
| Multivariate Analysis | 5 | 2017 | 1474 | 0.280 |
Why?
| Decision Making | 1 | 2013 | 809 | 0.280 |
Why?
| Health Behavior | 1 | 2012 | 720 | 0.280 |
Why?
| Juvenile Delinquency | 2 | 2004 | 103 | 0.280 |
Why?
| Diabetes Mellitus | 2 | 2014 | 942 | 0.280 |
Why?
| Hypoglycemia | 1 | 2010 | 400 | 0.270 |
Why?
| Retrospective Studies | 12 | 2016 | 12978 | 0.260 |
Why?
| Rural Population | 2 | 2007 | 452 | 0.260 |
Why?
| Family | 2 | 2006 | 585 | 0.260 |
Why?
| Longitudinal Studies | 7 | 2016 | 2513 | 0.260 |
Why?
| Stress, Psychological | 2 | 2010 | 972 | 0.260 |
Why?
| Suicide | 3 | 2007 | 500 | 0.260 |
Why?
| Ambulatory Care | 4 | 2014 | 482 | 0.260 |
Why?
| Aged | 18 | 2024 | 19657 | 0.250 |
Why?
| Parenting | 1 | 2008 | 252 | 0.250 |
Why?
| Curriculum | 3 | 2020 | 910 | 0.250 |
Why?
| Smoking | 1 | 2012 | 1487 | 0.250 |
Why?
| Crime | 1 | 2004 | 60 | 0.240 |
Why?
| Aged, 80 and over | 8 | 2015 | 6561 | 0.240 |
Why?
| Practice Patterns, Physicians' | 4 | 2007 | 1200 | 0.240 |
Why?
| Electronic Health Records | 3 | 2015 | 829 | 0.220 |
Why?
| Hypoglycemic Agents | 1 | 2010 | 1032 | 0.220 |
Why?
| Infant | 9 | 2017 | 8293 | 0.210 |
Why?
| Foster Home Care | 1 | 2003 | 65 | 0.210 |
Why?
| Residential Treatment | 1 | 2002 | 31 | 0.210 |
Why?
| Adolescent Psychiatry | 1 | 2002 | 12 | 0.210 |
Why?
| Anxiety Disorders | 1 | 2005 | 309 | 0.210 |
Why?
| Brain Injuries | 2 | 2005 | 484 | 0.210 |
Why?
| Child Psychiatry | 1 | 2002 | 30 | 0.200 |
Why?
| Contracts | 1 | 2001 | 9 | 0.200 |
Why?
| Logistic Models | 6 | 2017 | 1901 | 0.200 |
Why?
| Criminal Law | 1 | 2002 | 26 | 0.200 |
Why?
| Costs and Cost Analysis | 3 | 2010 | 202 | 0.200 |
Why?
| Health Surveys | 3 | 2010 | 454 | 0.200 |
Why?
| Severity of Illness Index | 6 | 2014 | 2674 | 0.190 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 505 | 0.190 |
Why?
| Schizophrenia | 1 | 2005 | 501 | 0.190 |
Why?
| Young Adult | 10 | 2017 | 10793 | 0.190 |
Why?
| Surface Plasmon Resonance | 1 | 2021 | 85 | 0.190 |
Why?
| Health Services Accessibility | 2 | 2007 | 781 | 0.190 |
Why?
| Women's Health | 2 | 2020 | 274 | 0.190 |
Why?
| Dried Blood Spot Testing | 1 | 2021 | 68 | 0.190 |
Why?
| Hypertension | 2 | 2022 | 1203 | 0.190 |
Why?
| Organophosphates | 1 | 2021 | 90 | 0.180 |
Why?
| Organizational Innovation | 2 | 2020 | 138 | 0.180 |
Why?
| Education | 1 | 2020 | 105 | 0.180 |
Why?
| Population Groups | 3 | 2017 | 58 | 0.170 |
Why?
| Adenine | 1 | 2021 | 223 | 0.170 |
Why?
| Suicidal Ideation | 2 | 2015 | 400 | 0.170 |
Why?
| Interdisciplinary Communication | 1 | 2020 | 191 | 0.170 |
Why?
| Hospitalization | 2 | 2011 | 1785 | 0.160 |
Why?
| Gender Identity | 1 | 2019 | 102 | 0.160 |
Why?
| Foundations | 1 | 2018 | 22 | 0.160 |
Why?
| Health Services Research | 3 | 2016 | 385 | 0.160 |
Why?
| Caregivers | 2 | 2020 | 709 | 0.160 |
Why?
| Program Evaluation | 5 | 2021 | 845 | 0.160 |
Why?
| Sexism | 1 | 2018 | 45 | 0.150 |
Why?
| Hospital Costs | 2 | 2012 | 110 | 0.150 |
Why?
| Chi-Square Distribution | 3 | 2012 | 525 | 0.150 |
Why?
| Program Development | 1 | 2019 | 357 | 0.150 |
Why?
| Attitude to Health | 2 | 2017 | 410 | 0.150 |
Why?
| Dose-Response Relationship, Drug | 2 | 2013 | 1945 | 0.150 |
Why?
| Leadership | 1 | 2020 | 311 | 0.150 |
Why?
| Veterans | 1 | 2007 | 1208 | 0.140 |
Why?
| Public Health Administration | 1 | 1997 | 78 | 0.140 |
Why?
| Risk Factors | 8 | 2012 | 9000 | 0.140 |
Why?
| Reminder Systems | 1 | 2017 | 163 | 0.140 |
Why?
| Alcoholism | 1 | 2002 | 717 | 0.130 |
Why?
| Immunization | 1 | 2017 | 412 | 0.130 |
Why?
| Comorbidity | 3 | 2015 | 1527 | 0.120 |
Why?
| Accidents | 2 | 2005 | 44 | 0.120 |
Why?
| Community Mental Health Services | 2 | 2007 | 83 | 0.120 |
Why?
| Quetiapine Fumarate | 1 | 2013 | 25 | 0.120 |
Why?
| Polypharmacy | 1 | 2014 | 75 | 0.120 |
Why?
| Interviews as Topic | 2 | 2020 | 599 | 0.120 |
Why?
| Oregon | 1 | 2013 | 69 | 0.120 |
Why?
| Decision Support Techniques | 2 | 2014 | 364 | 0.120 |
Why?
| Health Information Management | 1 | 2013 | 7 | 0.120 |
Why?
| Patient Satisfaction | 1 | 2017 | 610 | 0.120 |
Why?
| Alcohol-Related Disorders | 2 | 2005 | 111 | 0.120 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 403 | 0.110 |
Why?
| Health Expenditures | 2 | 2006 | 174 | 0.110 |
Why?
| Minority Groups | 2 | 2022 | 237 | 0.110 |
Why?
| Age Factors | 5 | 2012 | 2995 | 0.110 |
Why?
| Medical Audit | 1 | 2013 | 75 | 0.110 |
Why?
| Referral and Consultation | 1 | 2017 | 648 | 0.110 |
Why?
| Medical Records Systems, Computerized | 1 | 2013 | 92 | 0.110 |
Why?
| Women's Health Services | 2 | 2006 | 16 | 0.110 |
Why?
| Regression Analysis | 3 | 2011 | 983 | 0.110 |
Why?
| Economics, Pharmaceutical | 1 | 2012 | 10 | 0.110 |
Why?
| Prevalence | 3 | 2011 | 2326 | 0.110 |
Why?
| Analysis of Variance | 2 | 2014 | 1293 | 0.110 |
Why?
| Evidence-Based Medicine | 1 | 2016 | 693 | 0.110 |
Why?
| Education, Pharmacy, Graduate | 1 | 2012 | 21 | 0.110 |
Why?
| Diagnostic Tests, Routine | 1 | 2013 | 88 | 0.110 |
Why?
| Education, Graduate | 1 | 2012 | 36 | 0.110 |
Why?
| Efficiency | 1 | 2012 | 89 | 0.110 |
Why?
| Chemoembolization, Therapeutic | 1 | 2012 | 51 | 0.100 |
Why?
| Self Care | 1 | 2014 | 357 | 0.100 |
Why?
| Advisory Committees | 3 | 2007 | 212 | 0.100 |
Why?
| Maternal Age | 1 | 2012 | 122 | 0.100 |
Why?
| Health Services | 1 | 2012 | 110 | 0.100 |
Why?
| Infant, Small for Gestational Age | 1 | 2012 | 73 | 0.100 |
Why?
| Nausea | 1 | 2011 | 107 | 0.100 |
Why?
| Hospitals, University | 1 | 2012 | 172 | 0.100 |
Why?
| State Health Plans | 2 | 2002 | 31 | 0.100 |
Why?
| Patient-Centered Care | 1 | 2016 | 497 | 0.100 |
Why?
| Employment | 1 | 2012 | 135 | 0.100 |
Why?
| Psychomotor Agitation | 1 | 2011 | 71 | 0.100 |
Why?
| Vomiting | 1 | 2011 | 123 | 0.100 |
Why?
| Interinstitutional Relations | 1 | 2011 | 55 | 0.100 |
Why?
| Sexual Dysfunction, Physiological | 1 | 2011 | 60 | 0.100 |
Why?
| Insurance, Health, Reimbursement | 1 | 2012 | 88 | 0.100 |
Why?
| Medicare | 3 | 2024 | 663 | 0.100 |
Why?
| Radiography, Interventional | 1 | 2012 | 113 | 0.100 |
Why?
| Primary Health Care | 3 | 2010 | 1560 | 0.100 |
Why?
| Headache | 1 | 2011 | 128 | 0.100 |
Why?
| Policy Making | 1 | 2011 | 86 | 0.100 |
Why?
| Social Support | 2 | 2020 | 542 | 0.100 |
Why?
| Drug Labeling | 2 | 2007 | 45 | 0.100 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2011 | 102 | 0.090 |
Why?
| Computer Communication Networks | 1 | 2010 | 33 | 0.090 |
Why?
| Heart Transplantation | 1 | 2016 | 671 | 0.090 |
Why?
| Carcinoma, Hepatocellular | 1 | 2012 | 227 | 0.090 |
Why?
| Influenza, Human | 2 | 2017 | 554 | 0.090 |
Why?
| Medication Adherence | 1 | 2014 | 556 | 0.090 |
Why?
| Life Style | 1 | 2012 | 430 | 0.090 |
Why?
| Proportional Hazards Models | 3 | 2015 | 1125 | 0.090 |
Why?
| California | 3 | 2007 | 382 | 0.090 |
Why?
| Residence Characteristics | 1 | 2012 | 299 | 0.090 |
Why?
| Vaccination | 1 | 2017 | 1222 | 0.090 |
Why?
| Drug Utilization Review | 1 | 2009 | 60 | 0.090 |
Why?
| Surveys and Questionnaires | 4 | 2020 | 4708 | 0.090 |
Why?
| Financing, Government | 2 | 2000 | 40 | 0.080 |
Why?
| Information Dissemination | 1 | 2011 | 210 | 0.080 |
Why?
| Catheter Ablation | 1 | 2012 | 286 | 0.080 |
Why?
| HIV Infections | 2 | 2021 | 2459 | 0.080 |
Why?
| Prospective Studies | 3 | 2021 | 6471 | 0.080 |
Why?
| Community-Institutional Relations | 1 | 2009 | 91 | 0.080 |
Why?
| Drug Prescriptions | 2 | 2007 | 248 | 0.080 |
Why?
| Absorptiometry, Photon | 1 | 2009 | 229 | 0.080 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2007 | 37 | 0.080 |
Why?
| Liver Neoplasms | 1 | 2012 | 527 | 0.080 |
Why?
| Office Visits | 1 | 2007 | 83 | 0.080 |
Why?
| Drug Administration Schedule | 1 | 2009 | 736 | 0.080 |
Why?
| Databases, Factual | 4 | 2016 | 1231 | 0.070 |
Why?
| Infant, Newborn | 4 | 2012 | 5255 | 0.070 |
Why?
| Trauma Severity Indices | 2 | 2005 | 127 | 0.070 |
Why?
| Drug Utilization | 1 | 2007 | 169 | 0.070 |
Why?
| Sleep | 1 | 2011 | 660 | 0.070 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 239 | 0.070 |
Why?
| Alcohol Drinking | 1 | 2012 | 652 | 0.070 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2005 | 36 | 0.070 |
Why?
| Parent-Child Relations | 1 | 2008 | 232 | 0.070 |
Why?
| Physicians, Family | 1 | 2007 | 206 | 0.070 |
Why?
| Pilot Projects | 1 | 2010 | 1419 | 0.070 |
Why?
| Cost Savings | 2 | 2012 | 77 | 0.070 |
Why?
| Pregnancy | 2 | 2020 | 5691 | 0.060 |
Why?
| Bone Density | 1 | 2009 | 449 | 0.060 |
Why?
| Quality of Life | 1 | 2015 | 2366 | 0.060 |
Why?
| Qualitative Research | 2 | 2020 | 953 | 0.060 |
Why?
| Northwestern United States | 1 | 2004 | 56 | 0.060 |
Why?
| Florida | 1 | 2024 | 73 | 0.060 |
Why?
| Southwestern United States | 1 | 2004 | 94 | 0.060 |
Why?
| Age of Onset | 1 | 2005 | 467 | 0.060 |
Why?
| Direct Service Costs | 1 | 2003 | 10 | 0.060 |
Why?
| Psychiatry | 1 | 2007 | 201 | 0.060 |
Why?
| Treatment Outcome | 3 | 2013 | 9342 | 0.060 |
Why?
| Brain Damage, Chronic | 1 | 2003 | 24 | 0.060 |
Why?
| Volition | 1 | 2003 | 33 | 0.060 |
Why?
| Tobacco Use Disorder | 1 | 2005 | 233 | 0.060 |
Why?
| Odds Ratio | 2 | 2004 | 996 | 0.060 |
Why?
| Monte Carlo Method | 2 | 2014 | 146 | 0.060 |
Why?
| Sampling Studies | 1 | 2003 | 92 | 0.060 |
Why?
| Physician-Patient Relations | 1 | 2007 | 490 | 0.060 |
Why?
| Somatoform Disorders | 1 | 2003 | 38 | 0.060 |
Why?
| Marijuana Abuse | 1 | 2005 | 209 | 0.060 |
Why?
| Rehabilitation, Vocational | 1 | 2002 | 2 | 0.050 |
Why?
| Angiotensin Receptor Antagonists | 1 | 2022 | 84 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2022 | 117 | 0.050 |
Why?
| Cost Allocation | 1 | 2002 | 7 | 0.050 |
Why?
| Factor Analysis, Statistical | 1 | 2003 | 270 | 0.050 |
Why?
| Case-Control Studies | 1 | 2009 | 3171 | 0.050 |
Why?
| Reimbursement, Incentive | 1 | 2002 | 38 | 0.050 |
Why?
| Child Health Services | 2 | 2001 | 177 | 0.050 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 195 | 0.050 |
Why?
| Immunity | 1 | 2022 | 129 | 0.050 |
Why?
| Practice Management, Medical | 1 | 2001 | 35 | 0.050 |
Why?
| Confidence Intervals | 1 | 2002 | 324 | 0.050 |
Why?
| Data Interpretation, Statistical | 1 | 2003 | 336 | 0.050 |
Why?
| Adrenergic beta-Antagonists | 1 | 2022 | 301 | 0.050 |
Why?
| Adolescent Behavior | 1 | 2005 | 482 | 0.050 |
Why?
| Emergency Medical Services | 1 | 2007 | 589 | 0.050 |
Why?
| Occupational Diseases | 1 | 2002 | 136 | 0.050 |
Why?
| International Classification of Diseases | 2 | 2015 | 122 | 0.050 |
Why?
| Pediatrics | 1 | 2007 | 985 | 0.040 |
Why?
| Social Stigma | 1 | 2020 | 87 | 0.040 |
Why?
| Models, Statistical | 1 | 2003 | 636 | 0.040 |
Why?
| Risk Assessment | 3 | 2015 | 3057 | 0.040 |
Why?
| Carcinoma, Ductal, Breast | 1 | 1999 | 91 | 0.040 |
Why?
| Health Care Surveys | 2 | 1997 | 546 | 0.040 |
Why?
| Career Choice | 1 | 2019 | 192 | 0.040 |
Why?
| Competitive Bidding | 1 | 1997 | 3 | 0.040 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3360 | 0.040 |
Why?
| Decision Making, Organizational | 1 | 1997 | 25 | 0.040 |
Why?
| Administrative Personnel | 1 | 1997 | 33 | 0.040 |
Why?
| Motivation | 1 | 2001 | 506 | 0.040 |
Why?
| Blood Pressure | 1 | 2024 | 1664 | 0.040 |
Why?
| Pneumococcal Infections | 1 | 2017 | 96 | 0.040 |
Why?
| Specialization | 2 | 2007 | 120 | 0.040 |
Why?
| National Institute of Mental Health (U.S.) | 1 | 2016 | 5 | 0.030 |
Why?
| Pneumococcal Vaccines | 1 | 2017 | 140 | 0.030 |
Why?
| Models, Organizational | 1 | 1997 | 146 | 0.030 |
Why?
| Citalopram | 1 | 2015 | 27 | 0.030 |
Why?
| Focus Groups | 1 | 2017 | 387 | 0.030 |
Why?
| Medicine | 2 | 2007 | 106 | 0.030 |
Why?
| Immunization Programs | 1 | 2017 | 206 | 0.030 |
Why?
| Fluoxetine | 1 | 2015 | 47 | 0.030 |
Why?
| Clinical Protocols | 1 | 2016 | 238 | 0.030 |
Why?
| Uncertainty | 1 | 2014 | 101 | 0.030 |
Why?
| Urban Population | 1 | 1997 | 409 | 0.030 |
Why?
| Treatment Failure | 1 | 2015 | 341 | 0.030 |
Why?
| Reoperation | 1 | 2016 | 557 | 0.030 |
Why?
| Probability | 1 | 2014 | 305 | 0.030 |
Why?
| American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.030 |
Why?
| Insurance Claim Review | 1 | 2013 | 67 | 0.030 |
Why?
| Influenza Vaccines | 1 | 2017 | 500 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 812 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2015 | 965 | 0.030 |
Why?
| Schools, Pharmacy | 1 | 2012 | 52 | 0.030 |
Why?
| Linear Models | 1 | 2014 | 827 | 0.030 |
Why?
| Decision Trees | 1 | 2012 | 83 | 0.030 |
Why?
| Diabetes Complications | 1 | 2014 | 218 | 0.030 |
Why?
| Databases as Topic | 1 | 2011 | 73 | 0.030 |
Why?
| Models, Economic | 1 | 2012 | 48 | 0.030 |
Why?
| Health Care Rationing | 1 | 2011 | 48 | 0.020 |
Why?
| Faculty | 1 | 2012 | 135 | 0.020 |
Why?
| Radiotherapy | 1 | 2012 | 187 | 0.020 |
Why?
| Propensity Score | 1 | 2011 | 242 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 796 | 0.020 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 140 | 0.020 |
Why?
| Legislation, Medical | 1 | 2007 | 10 | 0.020 |
Why?
| Crisis Intervention | 1 | 2007 | 25 | 0.020 |
Why?
| Poverty Areas | 1 | 2007 | 35 | 0.020 |
Why?
| Appointments and Schedules | 1 | 2007 | 78 | 0.020 |
Why?
| Computer Simulation | 1 | 2012 | 922 | 0.020 |
Why?
| Students | 1 | 2012 | 509 | 0.020 |
Why?
| Breast Neoplasms | 1 | 1999 | 1965 | 0.020 |
Why?
| Least-Squares Analysis | 1 | 2006 | 73 | 0.020 |
Why?
| Drug Monitoring | 1 | 2007 | 187 | 0.020 |
Why?
| Ontario | 1 | 2006 | 111 | 0.020 |
Why?
| Osteoporosis | 1 | 2009 | 229 | 0.020 |
Why?
| Time Factors | 1 | 2016 | 6412 | 0.020 |
Why?
| Health Status Indicators | 1 | 2006 | 154 | 0.020 |
Why?
| Seasons | 1 | 2007 | 461 | 0.020 |
Why?
| Pandemics | 1 | 2011 | 1355 | 0.010 |
Why?
| Physician Incentive Plans | 1 | 2000 | 6 | 0.010 |
Why?
| Multicenter Studies as Topic | 1 | 2002 | 253 | 0.010 |
Why?
| Cost Control | 1 | 2000 | 44 | 0.010 |
Why?
| Hospital Mortality | 1 | 2005 | 814 | 0.010 |
Why?
| Adolescent Health Services | 1 | 2001 | 67 | 0.010 |
Why?
| Workplace | 1 | 2002 | 222 | 0.010 |
Why?
| Health Care Reform | 1 | 2000 | 95 | 0.010 |
Why?
| Primary Prevention | 1 | 2000 | 185 | 0.010 |
Why?
| Interpersonal Relations | 1 | 2002 | 345 | 0.010 |
Why?
| Incidence | 1 | 2005 | 2424 | 0.010 |
Why?
| Adenocarcinoma, Mucinous | 1 | 1999 | 59 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 4596 | 0.010 |
Why?
| Lymphatic Metastasis | 1 | 1999 | 307 | 0.010 |
Why?
| Quality Indicators, Health Care | 1 | 2000 | 295 | 0.010 |
Why?
| Disease-Free Survival | 1 | 1999 | 649 | 0.010 |
Why?
| Patient Care Team | 1 | 2002 | 521 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2002 | 1244 | 0.010 |
Why?
| Prognosis | 1 | 1999 | 3443 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|